Status:
UNKNOWN
Comparison of PD1+T Cell Expression in Peripheral Blood for Cardiac Function Prognosis in Patients With Acute MI
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
First People's Hospital of Hangzhou
Conditions:
PD1
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
Comparison of high PD1+ T cell and low PD1+ T cell expression in peripheral blood for cardiac function prognosis in Patients with acute myocardial infarction
Detailed Description
Myocardial infarction is a serious common disease in human beings. Although many patients with acute myocardial infarction survive with the improvement of medical technology in recent years, studies h...
Eligibility Criteria
Inclusion
- Over 18 years of age;
- Understand oral confirm to accept the risks and benefits of this experiment could bring He (she) or its legal representative in experiment related to provide written informed consent before surgery;
- Was diagnosed with st-elevation acute myocardial infarction;
- Based on the visual assessment of coronary angiography of coronary artery stenosis degree is 50% and the row stenting patients;
- The target vessels are limited to the main coronary arteries (including the left anterior descending, left circumflex, and right coronary arteries).
Exclusion
- Pregnant or lactating women; Patients with previous malignant tumors or mental diseases; Recent major trauma/trauma, or surgical treatment; Drug, drug and alcohol abusers; Those who have been receiving antitumor drugs, immunosuppressants, hormones and antibiotics for a long time; People with blood-borne infectious diseases (including hepatitis B, c, syphilis, AIDS, etc.);
- People with immune deficiency diseases or autoimmune diseases; Liver and kidney dysfunction; Aortic dissection, pulmonary embolism, acute myocarditis or severe valvular disease; One who is in the acute phase of any illness (influenza, pneumonia, gastroenteritis, skin disease, etc.).
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05251987
Start Date
October 1 2021
End Date
December 30 2022
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Zhejiang University, School of Medicine
Hangzhou, Zhejiang, China